7 Analysts Assess Encompass Health: What You Need To Know
Portfolio Pulse from Benzinga Insights
In the past three months, 7 analysts have provided ratings for Encompass Health (NYSE:EHC), ranging from bullish to bearish. The average 12-month price target has increased by 2.63% to $102.29. Analysts have made various adjustments to their ratings and price targets, reflecting their perceptions of the company's performance. Encompass Health has shown strong financial performance with significant revenue growth, high net margins, and efficient use of assets.
August 06, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health (NYSE:EHC) has received ratings from 7 analysts in the past three months, with an average 12-month price target of $102.29, up 2.63%. The company has shown strong financial performance with significant revenue growth, high net margins, and efficient use of assets.
The increase in the average price target and the positive financial performance metrics such as revenue growth, net margin, ROE, and ROA suggest a bullish outlook for Encompass Health in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100